• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患有囊性纤维化的非糖尿病儿童胃抑制多肽分泌过多。

Hypersecretion of gastric inhibitory polypeptide in nondiabetic children with cystic fibrosis.

作者信息

Ross S A, Morrison D, McArthur R G

出版信息

Pediatrics. 1981 Feb;67(2):252-4.

PMID:7017571
Abstract

Failure of secretion of an insulinotropic enteric hormone has been postulated as a cause for the impaired insulin secretion observed following a glycemic stimulus in children with cystic fibrosis (CF). Gastric inhibitory polypeptide (GIP), a hormone located primarily in the duodenum, is the main hormonal stimulus to insulin release from the gastrointestinal tract. To determine whether hyposecretion of GIP was present in CF subjects, GIP secretion was measured in 15 control children and ten children with CF, following a standard oral glucose tolerance test. None of the subjects was diabetic but the CF children demonstrated significant insulinopenia compared to the normal control subjects. GIP secretion in the CF children was significantly greater than in the normal control subjects (normal, 38.8 +/- 4.6 ng/ml . min; CF, 54.9 +/- 6.1 ng/ml . min, P less than .01). These findings indicate that there is increased production of GIP in CF children rather than impaired secretion as had been postulated. The demonstration of hypersecretion of GIP in nondiabetic insulinopenic individuals adds further support to the hypothesis that insulin exerts feedback control on GIP secretion.

摘要

胰岛素促分泌性肠激素分泌不足被认为是囊性纤维化(CF)患儿在血糖刺激后胰岛素分泌受损的一个原因。胃抑制性多肽(GIP)是一种主要位于十二指肠的激素,是胃肠道刺激胰岛素释放的主要激素。为了确定CF患者是否存在GIP分泌不足,在15名对照儿童和10名CF儿童中进行了标准口服葡萄糖耐量试验后测量了GIP分泌。所有受试者均无糖尿病,但与正常对照受试者相比,CF儿童表现出明显的胰岛素缺乏。CF儿童的GIP分泌明显高于正常对照受试者(正常,38.8±4.6 ng/ml·min;CF,54.9±6.1 ng/ml·min,P<0.01)。这些发现表明,CF儿童中GIP的产生增加,而不是如之前所假设的那样分泌受损。在非糖尿病性胰岛素缺乏个体中GIP分泌过多的证明进一步支持了胰岛素对GIP分泌施加反馈控制的假说。

相似文献

1
Hypersecretion of gastric inhibitory polypeptide in nondiabetic children with cystic fibrosis.患有囊性纤维化的非糖尿病儿童胃抑制多肽分泌过多。
Pediatrics. 1981 Feb;67(2):252-4.
2
Hypersecretion of gastric inhibitory polypeptide following oral glucose in diabetes mellitus.糖尿病患者口服葡萄糖后胃抑制性多肽分泌过多。
Diabetes. 1977 Jun;26(6):525-9. doi: 10.2337/diab.26.6.525.
3
Gastric inhibitory polypeptide (GIP) and insulin release in duodenal ulcer patients.十二指肠溃疡患者的胃抑肽(GIP)与胰岛素释放
J Clin Endocrinol Metab. 1978 Sep;47(3):615-9. doi: 10.1210/jcem-47-3-615.
4
Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels.口服葡萄糖对胰岛素分泌的增强作用。胃抑制性多肽与周围葡萄糖及胰岛素水平的相互作用。
J Clin Invest. 1978 Jul;62(1):152-61. doi: 10.1172/JCI109100.
5
Impaired feedback control of fat induced gastric inhibitory polypeptide (GIP) secretion by insulin in obesity and glucose intolerance.肥胖和葡萄糖不耐受时,胰岛素对脂肪诱导的胃抑制性多肽(GIP)分泌的反馈控制受损。
Eur J Clin Invest. 1979 Apr;9(2 Pt 1):129-35. doi: 10.1111/j.1365-2362.1979.tb01678.x.
6
Gastric inhibitory polypeptide (GIP) and insulin release in the obese Zucker rat.肥胖型 Zucker 大鼠中胃抑制多肽(GIP)与胰岛素释放
Diabetes. 1984 Jun;33(6):536-42. doi: 10.2337/diab.33.6.536.
7
Gastric inhibitory polypeptide secretion after radical pancreatoduodenectomy.根治性胰十二指肠切除术后胃抑制性多肽的分泌
Ann Surg. 1984 Mar;199(3):281-5. doi: 10.1097/00000658-198403000-00006.
8
Clinical aspects of GIP secretion.胃抑肽分泌的临床方面。
Acta Diabetol Lat. 1982 Jan-Mar;19(1):1-11. doi: 10.1007/BF02581180.
9
Interaction of fat-stimulated gastric inhibitory polypeptide on pancreatic alpha and beta cell function.脂肪刺激的胃抑制性多肽对胰腺α细胞和β细胞功能的相互作用。
J Clin Invest. 1980 May;65(5):1119-25. doi: 10.1172/JCI109765.
10
Hypersecretion of gastric inhibitory polypeptide induced by glucose ingestion in diabetes mellitus.糖尿病患者摄入葡萄糖后胃抑制性多肽分泌过多。
Endocrinol Jpn. 1981 Feb;28(1):17-21. doi: 10.1507/endocrj1954.28.17.

引用本文的文献

1
Hypoglycemia in children and young adults with cystic fibrosis during oral glucose tolerance testing vs. continuous glucose monitoring.儿童和青年囊性纤维化患者口服葡萄糖耐量试验与连续血糖监测期间的低血糖症。
Pediatr Pulmonol. 2023 Sep;58(9):2495-2504. doi: 10.1002/ppul.26533. Epub 2023 Jun 23.
2
Cystic fibrosis-related diabetes: optimizing care with a multidisciplinary approach.囊性纤维化相关糖尿病:采用多学科方法优化治疗
Diabetes Metab Syndr Obes. 2019 Apr 26;12:545-552. doi: 10.2147/DMSO.S180597. eCollection 2019.
3
Reduced β-Cell Secretory Capacity in Pancreatic-Insufficient, but Not Pancreatic-Sufficient, Cystic Fibrosis Despite Normal Glucose Tolerance.
尽管葡萄糖耐量正常,但胰腺功能不全而非胰腺功能正常的囊性纤维化患者的β细胞分泌能力降低。
Diabetes. 2017 Jan;66(1):134-144. doi: 10.2337/db16-0394. Epub 2016 Aug 5.
4
Abnormal endocrine pancreas function at birth in cystic fibrosis ferrets.出生时囊性纤维化雪貂的异常内分泌胰腺功能。
J Clin Invest. 2012 Oct;122(10):3755-68. doi: 10.1172/JCI60610. Epub 2012 Sep 17.
5
Clinical aspects of GIP secretion.胃抑肽分泌的临床方面。
Acta Diabetol Lat. 1982 Jan-Mar;19(1):1-11. doi: 10.1007/BF02581180.